These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 29512083)
21. Lower levels of the glial cell marker TSPO in drug-naive first-episode psychosis patients as measured using PET and [ Collste K; Plavén-Sigray P; Fatouros-Bergman H; Victorsson P; Schain M; Forsberg A; Amini N; Aeinehband S; ; Erhardt S; Halldin C; Flyckt L; Farde L; Cervenka S Mol Psychiatry; 2017 Jun; 22(6):850-856. PubMed ID: 28194003 [TBL] [Abstract][Full Text] [Related]
22. Reduction in Constitutively Activated Auditory Brainstem Microglia in Aging and Alzheimer's Disease. Butler T; Wang X; Chiang G; Xi K; Niogi S; Glodzik L; Li Y; Razlighi QR; Zhou L; Hojjati SH; Ozsahin I; Mao X; Maloney T; Tanzi E; Rahmouni N; Tissot C; Lussier F; Shah S; Shungu D; Gupta A; De Leon M; Mozley PD; Pascoal TA; Rosa-Neto P J Alzheimers Dis; 2024; 99(1):307-319. PubMed ID: 38669537 [TBL] [Abstract][Full Text] [Related]
23. Characterization of the 18 kDa translocator protein (TSPO) expression in post-mortem normal and Alzheimer's disease brains. Gui Y; Marks JD; Das S; Hyman BT; Serrano-Pozo A Brain Pathol; 2020 Jan; 30(1):151-164. PubMed ID: 31276244 [TBL] [Abstract][Full Text] [Related]
24. PET Imaging to Measure Neuroinflammation In Vivo. Malpetti M; Franzmeier N; Brendel M Methods Mol Biol; 2024; 2785():177-193. PubMed ID: 38427195 [TBL] [Abstract][Full Text] [Related]
25. Comparison of [11C]-PBR28 Binding Between Persons Living With HIV and HIV-Uninfected Individuals. Boerwinkle AH; Strain JF; Burdo T; Doyle J; Christensen J; Su Y; Wisch JK; Cooley SA; Vaida F; Smith MD; Jafri H; Paul RH; Benzinger TLS; Ances BM J Acquir Immune Defic Syndr; 2020 Oct; 85(2):244-251. PubMed ID: 32658129 [TBL] [Abstract][Full Text] [Related]
26. Brain translocator protein occupancy by ONO-2952 in healthy adults: A Phase 1 PET study using [ Frankle WG; Narendran R; Wood AT; Suto F; Himes ML; Kobayashi M; Ohno T; Yamauchi A; Mitsui K; Duffy K; Bruce M Synapse; 2017 Jul; 71(7):. PubMed ID: 28245513 [TBL] [Abstract][Full Text] [Related]
27. In vivo imaging of the 18-kDa translocator protein (TSPO) with [18F]FEDAA1106 and PET does not show increased binding in Alzheimer's disease patients. Varrone A; Mattsson P; Forsberg A; Takano A; Nag S; Gulyás B; Borg J; Boellaard R; Al-Tawil N; Eriksdotter M; Zimmermann T; Schultze-Mosgau M; Thiele A; Hoffmann A; Lammertsma AA; Halldin C Eur J Nucl Med Mol Imaging; 2013 Jun; 40(6):921-31. PubMed ID: 23436070 [TBL] [Abstract][Full Text] [Related]
28. Upregulation of cannabinoid receptor type 2, but not TSPO, in senescence-accelerated neuroinflammation in mice: a positron emission tomography study. Yamagishi S; Iga Y; Nakamura M; Takizawa C; Fukumoto D; Kakiuchi T; Nishiyama S; Ohba H; Tsukada H; Sato K; Ouchi Y J Neuroinflammation; 2019 Nov; 16(1):208. PubMed ID: 31707986 [TBL] [Abstract][Full Text] [Related]
29. PET imaging of microglia in Alzheimer's disease using copper-64 labeled TREM2 antibodies. Shojaei M; Schaefer R; Schlepckow K; Kunze LH; Struebing FL; Brunner B; Willem M; Bartos LM; Feiten A; Palumbo G; Arzberger T; Bartenstein P; Parico GC; Xia D; Monroe KM; Haass C; Brendel M; Lindner S Theranostics; 2024; 14(16):6319-6336. PubMed ID: 39431020 [TBL] [Abstract][Full Text] [Related]
30. The neuroinflammation marker translocator protein is not elevated in individuals with mild-to-moderate depression: a [¹¹C]PBR28 PET study. Hannestad J; DellaGioia N; Gallezot JD; Lim K; Nabulsi N; Esterlis I; Pittman B; Lee JY; O'Connor KC; Pelletier D; Carson RE Brain Behav Immun; 2013 Oct; 33():131-8. PubMed ID: 23850810 [TBL] [Abstract][Full Text] [Related]
31. Neuroinflammation PET imaging of the translocator protein (TSPO) in Alzheimer's disease: An update. Gouilly D; Saint-Aubert L; Ribeiro MJ; Salabert AS; Tauber C; Péran P; Arlicot N; Pariente J; Payoux P Eur J Neurosci; 2022 Mar; 55(5):1322-1343. PubMed ID: 35083791 [TBL] [Abstract][Full Text] [Related]
32. Visualization of brain amyloid and microglial activation in mouse models of Alzheimer's disease. Higuchi M Curr Alzheimer Res; 2009 Apr; 6(2):137-43. PubMed ID: 19355848 [TBL] [Abstract][Full Text] [Related]
33. Glial Activation and Glucose Metabolism in a Transgenic Amyloid Mouse Model: A Triple-Tracer PET Study. Brendel M; Probst F; Jaworska A; Overhoff F; Korzhova V; Albert NL; Beck R; Lindner S; Gildehaus FJ; Baumann K; Bartenstein P; Kleinberger G; Haass C; Herms J; Rominger A J Nucl Med; 2016 Jun; 57(6):954-60. PubMed ID: 26912428 [TBL] [Abstract][Full Text] [Related]
34. Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [18F]FEMPA in Alzheimer's disease patients and control subjects. Varrone A; Oikonen V; Forsberg A; Joutsa J; Takano A; Solin O; Haaparanta-Solin M; Nag S; Nakao R; Al-Tawil N; Wells LA; Rabiner EA; Valencia R; Schultze-Mosgau M; Thiele A; Vollmer S; Dyrks T; Lehmann L; Heinrich T; Hoffmann A; Nordberg A; Halldin C; Rinne JO Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):438-46. PubMed ID: 25412766 [TBL] [Abstract][Full Text] [Related]
35. Chaney A; Cropper HC; Johnson EM; Lechtenberg KJ; Peterson TC; Stevens MY; Buckwalter MS; James ML J Nucl Med; 2019 Jan; 60(1):122-128. PubMed ID: 29976695 [TBL] [Abstract][Full Text] [Related]
36. Early and protective microglial activation in Alzheimer's disease: a prospective study using 18F-DPA-714 PET imaging. Hamelin L; Lagarde J; Dorothée G; Leroy C; Labit M; Comley RA; de Souza LC; Corne H; Dauphinot L; Bertoux M; Dubois B; Gervais P; Colliot O; Potier MC; Bottlaender M; Sarazin M; Brain; 2016 Apr; 139(Pt 4):1252-64. PubMed ID: 26984188 [TBL] [Abstract][Full Text] [Related]
37. Microglial response to increasing amyloid load saturates with aging: a longitudinal dual tracer in vivo μPET-study. Blume T; Focke C; Peters F; Deussing M; Albert NL; Lindner S; Gildehaus FJ; von Ungern-Sternberg B; Ozmen L; Baumann K; Bartenstein P; Rominger A; Herms J; Brendel M J Neuroinflammation; 2018 Nov; 15(1):307. PubMed ID: 30400912 [TBL] [Abstract][Full Text] [Related]
38. PET imaging of translocator protein (18 kDa) in a mouse model of Alzheimer's disease using N-(2,5-dimethoxybenzyl)-2-18F-fluoro-N-(2-phenoxyphenyl)acetamide. James ML; Belichenko NP; Nguyen TV; Andrews LE; Ding Z; Liu H; Bodapati D; Arksey N; Shen B; Cheng Z; Wyss-Coray T; Gambhir SS; Longo FM; Chin FT J Nucl Med; 2015 Feb; 56(2):311-6. PubMed ID: 25613536 [TBL] [Abstract][Full Text] [Related]
39. Influence of alcoholism and cholesterol on TSPO binding in brain: PET [ Kim SW; Wiers CE; Tyler R; Shokri-Kojori E; Jang YJ; Zehra A; Freeman C; Ramirez V; Lindgren E; Miller G; Cabrera EA; Stodden T; Guo M; Demiral ŞB; Diazgranados N; Park L; Liow JS; Pike V; Morse C; Vendruscolo LF; Innis RB; Koob GF; Tomasi D; Wang GJ; Volkow ND Neuropsychopharmacology; 2018 Aug; 43(9):1832-1839. PubMed ID: 29777199 [TBL] [Abstract][Full Text] [Related]
40. Age and disease related changes in the translocator protein (TSPO) system in the human brain: positron emission tomography measurements with [11C]vinpocetine. Gulyás B; Vas A; Tóth M; Takano A; Varrone A; Cselényi Z; Schain M; Mattsson P; Halldin C Neuroimage; 2011 Jun; 56(3):1111-21. PubMed ID: 21320609 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]